+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Glucose Management Supplements - Global Strategic Business Report

  • PDF Icon

    Report

  • 375 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6094902
The global market for Glucose Management Supplements was valued at US$9.4 Billion in 2025 and is projected to reach US$13.8 Billion by 2032, growing at a CAGR of 5.7% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global 'Glucose Management Supplements' Market - Key Trends & Drivers Summarized

Why Are Glucose Management Supplements Gaining Popularity Among Health-Conscious Consumers?

Glucose management supplements are experiencing strong market growth as rising global awareness of prediabetes, insulin resistance, and blood sugar imbalances prompts individuals to seek preventative and adjunctive solutions. These supplements, often formulated with ingredients such as berberine, chromium, alpha-lipoic acid, cinnamon extract, and bitter melon, are marketed to help regulate blood sugar levels, support insulin sensitivity, and reduce post-meal glucose spikes. With over 1 billion people estimated to be prediabetic worldwide, there is a surging interest in non-pharmaceutical interventions to delay or prevent the onset of type 2 diabetes. Consumers - especially those pursuing natural wellness, functional nutrition, and lifestyle-based disease management - are increasingly incorporating glucose support supplements into daily routines, either as stand-alone interventions or in conjunction with diet and exercise programs.

What Innovations and Formulation Trends Are Emerging in This Supplement Category?

Manufacturers are responding to growing consumer demand by introducing advanced, evidence-backed formulations and delivery formats. Newer products feature bioavailable complexes, sustained-release capsules, and multi-ingredient blends that target glucose absorption, metabolism, and inflammatory pathways. Functional beverages, gummies, and powders are gaining traction, offering convenient alternatives to traditional tablets. Brands are also investing in clinical trials and third-party certifications to validate claims and differentiate themselves in a crowded market. Personalized nutrition is influencing product development, with some companies offering DNA-based or microbiome-informed supplement recommendations for glucose regulation. Additionally, plant-based and vegan-certified glucose supplements are aligning with broader dietary trends and expanding their reach among health-conscious millennials and aging populations alike.

How Are Regional Markets Responding to the Demand for Blood Sugar Support?

North America dominates the glucose management supplements market due to high consumer awareness, rising obesity rates, and a mature dietary supplement industry. The U.S. market, in particular, is fueled by a strong culture of self-care, direct-to-consumer marketing, and widespread retail distribution through pharmacies, health food stores, and e-commerce platforms. In Europe, demand is rising steadily as regulatory approval for functional claims grows more defined, especially in Germany, Italy, and the UK. The Asia-Pacific region is poised for the fastest growth, fueled by the increasing incidence of type 2 diabetes in India, China, and Southeast Asia, combined with traditional use of herbs like bitter melon and fenugreek. Meanwhile, Latin America and the Middle East are becoming emerging markets where a growing middle class and increased lifestyle disease awareness are driving supplement adoption.

What Are the Key Growth Drivers and Market Challenges Ahead?

The growth in the glucose management supplements market is driven by increased consumer interest in preventative health, the global burden of metabolic disorders, and growing trust in natural therapies. Supplements are being integrated into lifestyle medicine approaches, digital health coaching, and diabetes prevention programs, further expanding their relevance. However, the market faces challenges including inconsistent regulatory standards across regions, lack of transparency in some product claims, and potential consumer confusion due to overlapping wellness categories (e.g., weight loss, heart health, energy). Additionally, while supplements can support glucose health, they are not substitutes for medical treatment, requiring clearer positioning and responsible marketing. Despite these constraints, demand is expected to rise as consumers, practitioners, and healthcare systems increasingly embrace proactive, integrative approaches to metabolic wellness.

Report Scope

The report analyzes the Glucose Management Supplements market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Type (Alpha Lipoic Acid Type, Minerals Type, Vitamins Type, Other Types); Form (Tablet Form, Soft Gels Form, Capsule Form); Distribution Channel (Online Distribution Channel, Retail Distribution Channel)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Alpha Lipoic Acid Type segment, which is expected to reach US$6.4 Billion by 2032 with a CAGR of a 6.3%. The Minerals Type segment is also set to grow at 6.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $2.6 Billion in 2025, and China, forecasted to grow at an impressive 9.9% CAGR to reach $3.0 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Glucose Management Supplements Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Glucose Management Supplements Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Glucose Management Supplements Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, Akums Drugs and Pharmaceuticals Ltd., Amway Corporation, Arkopharma Laboratories, AksuVital Natural Products Co. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Glucose Management Supplements market report include:

  • Abbott Laboratories
  • Akums Drugs and Pharmaceuticals Ltd.
  • Amway Corporation
  • Arkopharma Laboratories
  • AksuVital Natural Products Co.
  • Blackmores Limited
  • Doctor's Best, Inc.
  • Douglas Laboratories
  • GNC Holdings, LLC
  • Herbalife Nutrition Ltd.
  • Himalaya Wellness Company
  • Jarrow Formulas, Inc.
  • Life Extension
  • Natrol LLC
  • Nature Made (Pharmavite LLC)
  • Nature's Bounty Co.
  • Nordic Naturals
  • NOW Foods
  • Nutricost
  • Orthomol Pharmazeutische Vertriebs GmbH
  • Pure Encapsulations, LLC
  • Solgar Inc.
  • Spring Valley (Walmart)
  • Swanson Health Products
  • Thorne Research, Inc.

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, the report extends market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • World Market Trajectories
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • Glucose Tolerance Tests - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Global Diabetes Prevalence Drives Widespread Adoption of Glucose Tolerance Testing
  • Growing Emphasis on Early Detection of Pre-Diabetes Expands Addressable Market for Screening Tests
  • Increased Public Health Spending in Emerging Economies Spurs Diagnostic Infrastructure Development
  • Integration of Glucose Tolerance Tests in Routine Health Checkups Enhances Market Penetration
  • Expansion of Preventive Healthcare Policies Strengthens Business Case for Mass Screening Programs
  • Technological Advancements in Diagnostic Analyzers Propel Accuracy and Adoption of Lab-Based Tests
  • Development of Portable and Point-of-Care Devices Accelerates Demand in Decentralized Settings
  • Adoption of Digital Health Platforms and Home-Based Testing Models Drives Market Transformation
  • Rising Geriatric Population and Associated Risk Factors Generate Sustained Demand for Testing Services
  • Growing Use of Glucose Tolerance Tests in Gestational Diabetes Screening Boosts Testing Volumes
  • Increasing Awareness Campaigns by NGOs and Health Authorities Amplify Demand for Diabetes Testing
  • Integration of AI and Data Analytics in Test Interpretation Enhances Diagnostic Value Proposition
  • Health Insurance Coverage Expansion in Developed Markets Spurs Utilization of Glucose Tolerance Tests
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Glucose Tolerance Tests Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Glucose Tolerance Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Glucose Tolerance Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Glucose Tolerance Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Smart Sensors Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Smart Sensors Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Smart Sensors Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Blood Glucose Testing Kit Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Blood Glucose Testing Kit Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Blood Glucose Testing Kit Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Meters Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Meters Product Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Meters Product Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Homecare Settings End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Homecare Settings End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Homecare Settings End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Diagnostic Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Diagnostic Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Diagnostic Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Hospitals & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Hospitals & Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Reactive Hypoglycemia Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Reactive Hypoglycemia Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Reactive Hypoglycemia Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Diabetes Hypoglycemia Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Diabetes Hypoglycemia Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Diabetes Hypoglycemia Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Gestational Diabetes Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Gestational Diabetes Disease Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Gestational Diabetes Disease Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 38: World Recent Past, Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 39: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: World 13-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Glucose Tolerance Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Akums Drugs and Pharmaceuticals Ltd.
  • Amway Corporation
  • Arkopharma Laboratories
  • AksuVital Natural Products Co.
  • Blackmores Limited
  • Doctor's Best, Inc.
  • Douglas Laboratories
  • GNC Holdings, LLC
  • Herbalife Nutrition Ltd.
  • Himalaya Wellness Company
  • Jarrow Formulas, Inc.
  • Life Extension
  • Natrol LLC
  • Nature Made (Pharmavite LLC)
  • Nature's Bounty Co.
  • Nordic Naturals
  • NOW Foods
  • Nutricost
  • Orthomol Pharmazeutische Vertriebs GmbH
  • Pure Encapsulations, LLC
  • Solgar Inc.
  • Spring Valley (Walmart)
  • Swanson Health Products
  • Thorne Research, Inc.

Table Information